Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRa) antibody drug conjugate (ADC), safety and efficacy in a broad distribution of FolRa expression in patients with recurrent epithelial ovarian cancer (OC): Update of STRO-002-GM1 phase 1 dose expansion cohort.
Luveltamab Tazevibulin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRa) antibody drug conjugate (ADC), safety and efficacy in a broad distribution of FolRa expression in patients with recurrent epithelial ovarian cancer (OC): Update of STRO-002-GM1 phase 1 dose expansion cohort. ### Output: Luveltamab Tazevibulin